The VEGFA-Induced MAPK-AKT/PTEN/TGFβ Signal Pathway Enhances Progression and MDR in Gastric Cancer
Genes · 2024
DOI: 10.3390/genes15101266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Hongming Fang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Shaanxi Normal University, 620 West Chang-An Street, Xi'an 710119, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Vascular Endothelial Growth Factor A, Drug Resistance, Neoplasm, PTEN Phosphohydrolase. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: G Nie, Guangxi Innovation-Driven Development Major Project.
Abstract (Originalsprache)
Background/Objectives: Gastric cancer (GC) is a globally frequent cancer, in particular leading in mortality caused by digestive tract cancers in China. Vascular endothelial growth factor A (VEGFA) is excessively expressed in cancers including GC; its involvement in GC development, particularly in multidrug resistance (MDR), and the signal route it affects in GC remain unknown. To explore the roles VEGFA plays during progression and MDR formation in GC, we studied its function in a VEGFA-deleted GC cell platform.
Methods
We initially assessed the importance of VEGFA in GC and MDR using database analysis. Then, using CCK8, wound healing, transwell, scanning electron microscopy, immunofluorescence, flow cytometry, and other techniques, the alterations in tumor malignancy-connected cell behaviors and microstructures were photographed and evaluated in a VEGFA-gene-deleted GC cell line (VEGFA−/−SGC7901). Finally, the mechanism of VEGFA in GC progression and MDR was examined by Western blot.
Results
Database analysis revealed a strong correlation between high VEGFA expression and a poor prognosis for GC. The results showed that VEGFA deletion reduced GC cell proliferation and motility and altered microstructures important for motility, such as the depolymerized cytoskeleton. VEGFA deletion inhibited the growth of pseudopodia/filopodia and suppressed the epithelial–mesenchymal transition (EMT). The occurrence of MDR is induced by overactivation of the MAPK-AKT and TGFβ signaling pathways, while PTEN inhibits these pathways.
Conclusions
All findings suggested that VEGFA acts as a cancer enhancer and MDR inducer in GC via the MAPK-AKT/PTEN/TGFβ signal pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Shaanxi Normal University, 620 West Chang-An Street, Xi'an 710119, China.
- Guangxi Key Laboratory of Agricultural Resource Chemistry and Biotechnology, 299 Jiao-Yu-Zhong Road, Yulin 537000, China.
- School of Medicine, Deakin University, and IMPACT Strategic Research Centre, Melbourne, VIC 3216, Australia.
ORCID-Profile: Hongming Fang, Qingmei Chen
Förderung
- G Nie
- Guangxi Innovation-Driven Development Major Project
Zitieren
APA
Fang, H., Zhou, Y., Bai, X., Che, W., Zhang, W., Zhang, D., Chen, Q., Duan, W., Nie, G., & Hou, Y. (2024). The VEGFA-Induced MAPK-AKT/PTEN/TGFβ Signal Pathway Enhances Progression and MDR in Gastric Cancer. Genes. https://doi.org/10.3390/genes15101266
Vancouver
Fang H, Zhou Y, Bai X, Che W, Zhang W, Zhang D, et al. The VEGFA-Induced MAPK-AKT/PTEN/TGFβ Signal Pathway Enhances Progression and MDR in Gastric Cancer. Genes. 2024. doi:10.3390/genes15101266
BibTeX
@article{Fang2024,
author = {Fang, Hongming and Zhou, Yujuan and Bai, Xue and Che, Wanlin and Zhang, Wenxuan and Zhang, Danying and Chen, Qingmei and Duan, Wei and Nie, Guochao and Hou, Yingchun},
title = {The VEGFA-Induced MAPK-AKT/PTEN/TGFβ Signal Pathway Enhances Progression and MDR in Gastric Cancer},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15101266}
}
EUVIMED